Page last updated: 2024-09-03
cgs 26129 and rb 104
cgs 26129 has been researched along with rb 104 in 1 studies
Compound Research Comparison
| Studies (cgs 26129) | Trials (cgs 26129) | Recent Studies (post-2010) (cgs 26129) | Studies (rb 104) | Trials (rb 104) | Recent Studies (post-2010) (rb 104) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 7 | 0 | 0 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Burrell, LM; Casely, D; Farina, N; Johnston, CI; Risvanis, J; Woollard, D | 1 |
Other Studies
1 other study(ies) available for cgs 26129 and rb 104
| Article | Year |
|---|---|
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Binding, Competitive; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Iodine Radioisotopes; Iodobenzenes; Kidney; Methionine; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Renin; Time Factors | 1997 |